Von Hippel-Lindau disease and renal cancer : ten years of genetic progress;Maladie de von Hippel-Lindau et cancer du rein : Dix ans de progrès génétiques

Progres en Urologie

Volumn 8, Issue 3, 1998, Pages 330-339

  Richard, Stéphane ^a,b   Beroud, Christophe ^a   Joly, Dominique ^a   Chretien, Yves ^a   Benoit, Gérard ^b  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

^b BICÊTRE HOSPITAL   (France)

Author keywords

Genetics; Renal cancer; Van hippel lindau

Indexed keywords

ADENOCARCINOMA; ADOLESCENT; ADULT; AGED; ANIMAL; CHROMOSOME 3; CHROMOSOME DELETION; COMPARATIVE STUDY; FEMALE; GENETIC TRANSCRIPTION; GENETICS; GENOTYPE; GROWTH, DEVELOPMENT AND AGING; HUMAN; KIDNEY TUMOR; MALE; MIDDLE AGED; MOUSE; MUTATION; PEDIGREE; PHENOTYPE; PLACENTA; PREGNANCY; REVIEW; TIME; VON HIPPEL LINDAU DISEASE;

ADENOCARCINOMA, CLEAR CELL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANIMALS; CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 3; FEMALE; GENOTYPE; HIPPEL-LINDAU DISEASE; HUMANS; KIDNEY NEOPLASMS; MALE; MICE; MIDDLE AGED; MUTATION; PEDIGREE; PHENOTYPE; PLACENTA; PREGNANCY; TIME FACTORS; TRANSCRIPTION, GENETIC;

EID: 0032084479     PISSN: 11667087     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (76)

1. ASO T., HAQUE D., BARSTEAD R.J., CONAWAY R.C., CONAWAY J.W. The inducible elongin A elongation activation domain: structure, function and interaction with the elongin BC complex. EMBO J., 1996, 15, 5557-5566.
2. BAILLY M., BAIN C., FAVROT M.C , OZTURK M. Somatic mutations of von Hippel-Lindau (VHL) tumor-suppressor gene in European kidney cancer Int. J. Cancer. 1995, 63, 660-664.
3. BEROUD C., JOLY D., ORFANELLI M.T., JUNIEN C. Software and database for the analysis of mutations in the VHL gene. Nucl. Acid Res., in press.
4. BRAUCH H , KISHIDA T , GLAVAC D , et al. Von Hippel-Lindau (VHL) disease with pheochromocytoma in the Black Forest region of Germany: evidence for a founder effect. Hum. Genet ,1995, 95, 551-556.
5. BROWNE G., JEFFERSON J.A., WRIGHT G.D., et al. Von Hippel-Lindau disease, an important differential diagnosis of polycystic kidney disease. Nephrol. Dial Transplant., 1997, 12, 1132-1136
6. CHAUVEAU D., DUVIC C., CHRETIEN Y., et al. Renal involvement in von Hippel-Lindau disease. Kidney Int., 1996, 50, 944-951.
7. CHEN F., KISHIDA T., DUH F.M., et al. Suppression of growth of renal carcinoma cells by the von Hippel-Lindau tumor suppressor gene Cancer Res , 1995, 55, 4804-4807.
8. CHEN F., KISHIDA T. YAO M , et al. Germline mutations in the Von Hippel-Lindau disease tumor suppressor gene: correlations with phenotype. Hum Mutat ,1995, 5, 66-75.
9. CHOYKE P , GLENN G.M., WALTHER M.M , et al The natural history of renal lesions in von Hippel-Lindau disease. A serial study in 28 patients Am. J. Roentgenol. 1992, 159, 1229-1234.
10. CHOYKE P L., GLENN G.M., WAGNER J P., et al Epididymal cystadenomas in von Hippel-Lindau Urology, 1997, 49, 926-931
11. COHEN A.J., LI F P., BERG S., et al. Hereditary renal-cell carcinoma associateD with a chromosomal translocation N.Engl J. Med , 1979, 301, 592-595
12. CHRETIEN Y., CHAUVEAU D., RICHARD S., et al Traitement de la maladie de von Hippel-Lindau avec atteinte rénale. Prog. Urol., 1997, in press
13. DECKER H.J.H., WEIDT E J., BRIEGER J. The von Hippel-Lindau tumor suppressor gene. A rare and intriguing disease opening new insights into basic mechanisms of carcinogenesis. Cancer Genet. Cytogenet., 1997, 93, 74-83.
14. DUAN D.R., PAUSE A., BURGESS W.H., et al. Inhibition of transcription elongation by the VHL tumor suppressor protein. Science, 1995, 269, 1402-1406.
15. ENG C., CROSSEY P.A., MULLIGAN L.M., et al. Mutations in the RET protooncogene and the von Hippel-Lindau disease tumour suppressor gene in sporadic and syndromic pheochromocytoma. J. Med. Genet., 1995, 32, 934-937.
16. FOURNIER G., VALERI A., CUSSENOT O. Formes familiales des cancers de l'appareil urogénital. Prog. Urol., 1996, 6, 343-355.
17. GILCREASE M.Z., SCHMIDT L., ZBAR B., TRUONG L., RUTLEDGE M. WHEELER T.M. Somatic von Hippel-Lindau gene mutation in clear cell papillary cystadenoma of the epididymis. Hum. Pathol., 1995, 26, 1341-1346.
18. GNARRA J.R., TORY K., WENG Y., et al. Mutations of the VHL tumour suppressor gene in renal cell carcinoma. Nature Genet., 1994, 7, 85-89.
19. GNARRA J.R., ZHOU S., MERRILL M.J., et al. Post-transcriptional regulation of vascular endothelial growth factor mRNA by the product of the VHL tumor suppressor gene. Proc. Natl. Acad. Sci. USA. 1996, 93, 10589-10594.
20. GNARRA J.R., WARD J.M., PORTER F.D., et al. Defective placental vasculogenesis causes embryonic lethality in VHL-deficient mice. Proc. Natl. Acad. Sci. USA, 1997, 94, 9102-9107.
21. GOLDFARB D. Nephron-sparing surgery and renal transplantation in VHL patients with renal cell carcinoma. Sixth MEN-VHL Workshop, Noordwijkerhout, 26-28 juin 1997. Abstr. 127.
22. HAMMEL P., BEIGELMAN C., CHAUVEAU D., et al. Variété des lésions pancréatiques au cours de la maladie de von Hippel-Lindau. Gastroentérol. Clin. Biol., 1995, 19, 1011-1017.
23. HATVA E., BOHLING T., JAASKELAINEN J., PERSICO M.G., HALTIA M., ALITALO K. Vascular growth factors and receptors in capillary hemangioblastomas and hemangiopericytomas. Am J. Pathol., 1996, 148, 763-775
24. HERMAN J.G., LATIF F., WENG Y., et al. Silencing of the VHL tumor-suppressor gene by DNA methylation in renal cell carcinoma Proc. Natl. Acad. Sci. US.A 1995, 91: 9700-9704.
25. ILIOPOULOS O., LEVY A.P., JIANG C., KAELIN W.G., GOLDBERG M.A. Negative regulation of hypoxia-inducible genes by the von Hippel-Lindau protein. Proc. Natl. Acad. Sci. USA. 1996, 93, 10595-10599.
26. KANNO H., KONDO K., ITO S., et al. Somatic mutations of the von Hippel-Lindau tumor suppressor gene in sporadic central nervous system hemangioblastoma. Cancer Res, 1994, 54, 4845-4847.
27. KEMPERMANN G., NEUMANN H.PH., SCHEREMET R., et al. Deafness due to bilateral endolymphatic sac tumors in a case of von Hippel-Lindau syndrome. J Neurol. Neurosurg. Psychiatr., 1996, 61, 318-320.
28. KIBEL A., ILIOPOULOS O., DECAPRIO J.A., KAELIN W.G. Binding of the von Hippel-Lindau tumor suppressor protein to Elongin B. and C. Science. 1995, 269, 1444-1446.
29. KISHIDA T., STACKOUSE T M., CHEN F , LERMAN M.I., ZBAR B. Cellular proteins that bind the von Hippel-Lindau disease gene product mapping of binding domains and the effect of missenses mutations. Cancer Res,1995, 55: 4544-4548.
30. KOVACS G. Molecular cylogenetics of renal tumours. Adv. Cancer Res., 1993, 62, 89-97.
31. KRAGEL P.J., WALTHER M.M., PESTANER J.P., FILLINGKATZ M.R. Simple renal cysts, atypical renal cysts, and renal cell carcinoma in von Hippel-Lindau disease' a lectin and immunohistochemical study in six patients. Mod. Pathol., 1990, 4, 210-214.
32. KUZMIN I., DUH F.M., GEIL L., ZBAR B., LERMAN M.I. Identification of the promoter of the human von Hippel-Lindau disease tumor suppressor gene. Oncogene, 1995, 10, 2185-2194.
33. LAMIELL J.M., SALAZAR F.G., HSIA Y.E. Von Hippel-Lindau disease affecting 43 members of a single kindred. Medicine, 1989, 68, 1-29.
34. LATIF F., TORY K., GNARRA J., et al. Identification of the von Hippel-Lindau disease tumor suppressor gene. Science, 1993, 260,1317-1320.
35. LEE S., CHEN D.Y.T., HUMPHREY J.S., GNARRA J.R., LINEHAN W.M., KLAUSNER R.D. Nuclear/cytoplasmic localization of the von Hippel-Lindau tumor suppressor gene product is determined by cell density. Proc. Natl. Acad. Sci. USA, 1996, 93, 1770-1775.
36. LEVY A P., LEVY N.S., GOLDBERG M.A. Hypoxia-inducible protein binding to vascular endothelial growth factor mRNA ant its modulation by the von HippelLindau protein. J. Biom. Chem., 1996, 271, 25492-25497.
37. LINDAU A. Studien uber Kleinhirnzysten. Bau, Pathogenese und Beziehungen zur Angiomatosis retinae. Acta Pathol. Microbiol. Scand., 1926, S 1, 1-128.
38. LINEHAN W.M., LERMAN M.I., ZBAR B. Identification of the von Hippel-Lindau (VHL) gene. Its role in renal cancer. J.A.M.A., 1995, 273, 564-570.
39. LOS M., JANSEN G.H., KAELIN W.G., LIPS C.J.M., BLIJHAM G.H.B , VOEST E E. Expression pattern of the von Hippel-Lindau protein in human tissues. Lab. Invest.,1996, 75, 231-238.
40. LUBENSKY I.A., GNARRA J.R., BERTHEAU P., WALTHER M.M.C , LINF W.M., ZHUANG Z. Allelic deletions of the VHL gene detected in multiple microscopic clear cell renal lesions in von Hippel-Lindau disease patients Am. J. Pathol., 1996, 149, 2089-2094.
41. MADDOCK I.R., MORAN A., MAHER E.R., et al. A genetic register for von HippelLindau disease. J. Med. Genet , 1996, 33,120-127.
42. MAHER E.R, MOORE A.T. Von Hippel-Lindau disease. Br. J. Ophthalmol., 1992, 76, 743-745.
43. MAHER E.R., YATES J.R.W., FERGUSON-SMITH M.A Statistical analysis of the two stage mutation model in von Hippel-Lindau disease, and in sporadic cerebellar haemangioblastoma and renal cell carcinoma. J. Med. Genet., 1990, 27, 311-314.
44. MAHER E.R., YATES J.R.W., HARRIES R., et al. Clinical features and natural history of Von Hippel-Lindau disease Q J , Med ., 1990, 77,1151-1156.
45. MANSKI T.J., HEFFNER D.K , GLENN G.M., et al. Endolymphatic sac tumors. A source of hearing loss in von Hippel-Lindau disease. JAMA. 1997, 277, 1461-1466.
46. MUKHOPADHYAY D., KNEBELMANN B., COHEN H.T., ANANTH S., SUKHATME V.P. The von Hippel-Lindau tumor suppressor gene product interacts with Sp1 to repress vascular endothelial growth factor promoter activity. Mol. Cel Biol., 1997, 17, 5629-5639.
47. NEUMANN H.P.H., WIESTLER OD. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet,1991, 337, 1052-1054.
48. NEUMANN H.PH., BERGER D.P., SIGMUND G., et al. Pheochromocytomas, multiple endocrine neoplasia type 2, and von Hippel-Lindau disease N. Engl. J Med., 1993, 329, 1531-1538.
49. NEUMANN H.PH., ENG C., MULLIGAN L.M., et al. Consequences of direct genetic testing for germline mutations in the clinical management of families with mutiple endocrine neoplasia type II , JAMA, 1995, 274, 1149-1151.
50. NEUMANN H.P.H., BENDER B.U., JANUSZEWICZ A., JANETSCHEK G., ENG C. Phéochromocytome familial. In: Actualités Néphrologtques Jean Hamburger, GRUNFELD J.P., BACH J.F., KREIS H. eds. Médecine-Sciences Flammarion 1997, 337-350.
51. NEUMANN H.P.H., ZBAR B. Renal cysts, renal cancer and von Hippel-Lindau disease. Kidney Int., 1997, 51, 16-26.
52. NIEMELA M , LIM Y J., SÖDERMAN M., JAASKELAINAINEN J., LINDQUIST, C. Gamma knife radiosurgery in 11 hemangioblastoma. J. Neurosurg., 1996, 85, 591-596.
53. OBERSTRASS J, REIFENBERGER G., WECHSLER W., COLLINS V.P. Mutation of the von Hippel-Lindau tumour suppressor gene in capillary haemangioblastomas of the central nervous system. J Pathol., 1996, 179, 151-156.
54. OLSCHWANG S., BOISSON C., RICHARD S., RESCHE F., THOMAS G. DNA-based presymptomatic diagnosis for the von Hippel-Lindau disease by linkage analysis. Eur. J. Hum. Genet , 1995, 3, 108-115.
55. PROWSE A., WEBSTER A.R., RICHARDS F.M., et al. Somatic mactivation of the VHL gene in von Hippel-Lindau disease tumours. Am. J. Hum. Genet , 1997, 60, 765-771.
56. RESCHE F., MOISAN J.P., MANTOURA J., et al. Hemangioblastomas, hemangioblastomatosis and von Hippel-Lindau disease. Adv. Techn. Stand. Neurosurg., 1993, 20, 197-303.
57. RICHARD S , CHAUVEAU D., CHRETIEN Y., et al. Renal lesions and pheochromocytoma in von Hippel-Lindau disease. Adv. Nephrol., 1994A, 23, 1-27
58. RICHARD S., BEIGELMAN C., DUCLOS J.M., et al. Pheochromocytoma as the first manifestation of von Hippel-Lindau disease. Surgery, 1994B, 116, 1076-1081.
59. RICHARD S , BEIGELMAN C., GERBER S., et al L'hémangioblastome existe t-il en dehors de la maladie de von Hippel-Lindau? Neurochir, 1994C, 40, 145-154.
60. RICHARD S., OLSCHWANG S , CHAUVEAU D., RESCHE F. La maladie de von Hippel-Lindau. Médecine-Sciences, 1995, 11, 43-51.
61. RICHARD S , CAMPELLO C., TAILLANDIER L., PARKER F., RESCUE F. Hemangioblastoma of the central nervous system in von Hippel-Lindau disease. J. Intern. Med., 1997, in press.
62. RICHARDS F.M., CROSSEY P A., PHIPPS M.E. et al. Detailed mapping of germline deletions of the von Hippel-Lindau disease lumour suppressor gene Hum Molec. Genet., 1994, 3, 595-598.
63. RICHARDS F.M., PAYNE S.J., ZBAR B., AFFARA N A., FERGUSON SMITH M A., MAHER E.R. Molecular analysis of de novo germline mutations in the von Hippel-Lindau disease gene. Hum Molec. Genet. 1995, 4, 2139-2143.
64. ROUQUETTE I., CERVERA P., RICHARD S. URO E., DAUMAS-DUPORT C., DELISLE M.B. Adénocarcinome papillaire de bas grade du sac endolymphatique Ann Pathol., 1996, 16, 271-275.
65. SEIZINGER B.R , ROULEAU G.A., OZELIUS L J., et al.Von Hippel Lindau disease maps to the region of chromosome 3 associated with renal cell carcinoma. Nature, 1988, 332, 268-2689
66. SHUIN T., KONDO K , TORIGOE S., et al. Frequent somatic mutations and loss of heterozygosity of the von Hippel-Lindau tumor suppressor gene in primary human renal cell carcinomas Cancel Res., 1994, 54, 2852-2855.
67. SOLOMON D., SCHWARTZ A. Renal pathology in von Hippel-Lindau disease. Hum. Pathol., 1988, 19, 1072-1079.
68. Statement of the American Society of Clinical Oncology: Genetic testing for cancer susceptibility. J. Clin. Oncol., 1996, 14,1730-1736.
69. STEINBACH F., NOVIVK, A.C., SHOSKES D., et al. Renal transplantation in patients with renal cell carcinoma and von Hippel-Lindau disease. Urology, 1994, 44, 760-763.
70. STEINBACH F., NOVICK A.C., ZINCKE H., et al. Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicentric study. J. Urol., 1995, 153, 1812-1816.
71. TORY K.H., BRAUCH H., LINEMAN M. et al. Specific genetic change in tumors associated with von Hippel-Lindau disease. J Natl. Cancer Inst., 1989, 81, 1097-1101.
72. VON HIPPEL E. Vorstellung eines Patienten mit einer sehr ungewohnlichen Netzhaut. XXIV Verstellung der ophthalmologischen Gesellschaft (Heidelberg, 1895), J.F. Bergmann Verlag, Wiesbaden 269.
73. VORTMEYER A O , LUBENSKY I.A., FOOT F., LINEHAN W.M., KHETTRY U., ZHUANG Z. Allelic deletion and mutation of the von Hippel-Lindau (VHL) tumor suppressor gene in pancreatic microcystic adenomas. Am. J. Pathol., 1997, 151, 951-956.
74. WIZIGMANN-VOOS S., BREUIER G., RISAU W., PLATE K.H. Upregulation of vascular endothelial growth factor and its receptors in von Hippel-Lindau disease-associated and sporadic hemangioblastoma. Cancer Res., 1995, 55, 1358-1364.
75. ZBAR B., KISHIDA T., CHEN F., et al. Germline mutations in the von Hippel-Lindau (VHL) gene in families from North America. Europe and Japan Hum. Mutat.,1996, 8, 348-357.
76. ZBAR B., LERMAN M Inherited carcinomas of the kidneys. Adv. Cancer Res., in press.